Novo Nordisk announced Thursday that it is pursuing legal action against two compounding pharmacies for allegedly selling ...
On Tuesday morning, San Francisco-based biotech company Loyal announced a significant step towards the approval of their life ...
Enhanced 250kg manufacturing facility assures increased capacity to meet rapidly growing ZTlido® demand.Two new patents previously announced covering ZTlido® in the U.S. ensures proprietary protection ...
The FDA has accepted for review the New Drug Application for OX124 for the treatment of opioid overdose. The Food and Drug Administration ... President and CEO of Orexo. “With approval, we intend to ...
ATAI Life Sciences is revolutionizing mental health treatment with psychedelic-based therapies. Read an investment analysis ...
A San Francisco-based company is working to launch a drug that could make dogs live longer and healthier lives. If approved ...
Along with its eye-opening trailer, HERO offers services including a family support group, grief support group, drug ...
On Tuesday, Loyal for Dogs announced the first formal acceptance from the FDA that the drug named LOY-001 can be developed ...
The FDA is expected to decide by the end of next week whether to approve the first gene-editing therapy in the U.S., just weeks after the treatment for a rare genetic blood disorder received ...
T he US Food and Drug Administration (FDA) has accepted Orexo’s new drug application (NDA) for opioid overdose medication, ...
Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY), today announces the New Drug Application (NDA) for OX124 has been accepted for review by the US Food and Drug Administration (FDA). OX124 is a nasal rescue ...
Tianeptine, sold in tasty-sounding flavors like chocolate vanilla, cherry and tropical — has caused seizures, loss of ...
